Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Using Patients' Social Network to Improve Compliance to Outpatient Screening Colonoscopy Appointments Among Blacks: A Randomized Clinical Trial.

Laiyemo AO, Kwagyan J, Williams CD, Rogers J, Kibreab A, Jack MA, Lee EE, Brim H, Ashktorab H, Howell CD, Smoot DT, Platz EA.

Am J Gastroenterol. 2019 Oct;114(10):1671-1677. doi: 10.14309/ajg.0000000000000387.

PMID:
31478919
2.

CDX1 Expression Induced by CagA-Expressing Helicobacter pylori Promotes Gastric Tumorigenesis.

Choi SI, Yoon C, Park MR, Lee D, Kook MC, Lin JX, Kang JH, Ashktorab H, Smoot DT, Yoon SS, Cho SJ.

Mol Cancer Res. 2019 Aug 15. doi: 10.1158/1541-7786.MCR-19-0181. [Epub ahead of print]

PMID:
31416838
3.

Genipin induces mitochondrial dysfunction and apoptosis via downregulation of Stat3/mcl-1 pathway in gastric cancer.

Jo MJ, Jeong S, Yun HK, Kim DY, Kim BR, Kim JL, Na YJ, Park SH, Jeong YA, Kim BG, Ashktorab H, Smoot DT, Heo JY, Han J, Lee DH, Oh SC.

BMC Cancer. 2019 Jul 27;19(1):739. doi: 10.1186/s12885-019-5957-x.

4.

HNF4α pathway mapping identifies wild-type IDH1 as a targetable metabolic node in gastric cancer.

Xu C, Ooi WF, Qamra A, Tan J, Chua BY, Ho SWT, Das K, Adam Isa ZF, Li Z, Yao X, Yan T, Xing M, Huang KK, Lin JS, Nandi T, Tay ST, Lee MH, Tan ALK, Ong X, Ashktorab H, Smoot D, Li S, Ng SC, Teh BT, Tan P.

Gut. 2019 May 8. pii: gutjnl-2018-318025. doi: 10.1136/gutjnl-2018-318025. [Epub ahead of print]

PMID:
31068366
5.

NKX6.3 protects against gastric mucosal atrophy by downregulating β-amyloid production.

Yoon JH, Lee YS, Kim O, Ashktorab H, Smoot DT, Nam SW, Park WS.

World J Gastroenterol. 2019 Jan 21;25(3):330-345. doi: 10.3748/wjg.v25.i3.330.

6.

Association of Health Literacy and Numeracy with Interest in Research Participation.

Kripalani S, Heerman WJ, Patel NJ, Jackson N, Goggins K, Rothman RL, Yeh VM, Wallston KA, Smoot DT, Wilkins CH.

J Gen Intern Med. 2019 Apr;34(4):544-551. doi: 10.1007/s11606-018-4766-2. Epub 2019 Jan 25.

PMID:
30684202
7.

Identification of Specific Oral and Gut Pathogens in Full Thickness Colon of Colitis Patients: Implications for Colon Motility.

Dinakaran V, Mandape SN, Shuba K, Pratap S, Sakhare SS, Tabatabai MA, Smoot DT, Farmer-Dixon CM, Kesavalu LN, Adunyah SE, Southerland JH, Gangula PR.

Front Microbiol. 2019 Jan 4;9:3220. doi: 10.3389/fmicb.2018.03220. eCollection 2018.

8.

Correction: Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.

Kang MH, Jeong GS, Smoot DT, Ashktorab H, Hwang CM, Kim BS, Kim HS, Park YY.

Oncotarget. 2018 Dec 14;9(98):37268. doi: 10.18632/oncotarget.26488. eCollection 2018 Dec 14.

9.

Vitamin D3 activates the autolysosomal degradation function against Helicobacter pylori through the PDIA3 receptor in gastric epithelial cells.

Hu W, Zhang L, Li MX, Shen J, Liu XD, Xiao ZG, Wu DL, Ho IHT, Wu JCY, Cheung CKY, Zhang YC, Lau AHY, Ashktorab H, Smoot DT, Fang EF, Chan MTV, Gin T, Gong W, Wu WKK, Cho CH.

Autophagy. 2019 Apr;15(4):707-725. doi: 10.1080/15548627.2018.1557835. Epub 2019 Jan 6.

10.

Novel circular RNA NF1 acts as a molecular sponge, promoting gastric cancer by absorbing miR-16.

Wang Z, Ma K, Pitts S, Cheng Y, Liu X, Ke X, Kovaka S, Ashktorab H, Smoot DT, Schatz M, Wang Z, Meltzer SJ.

Endocr Relat Cancer. 2018 Dec 1. pii: ERC-18-0478.R1. doi: 10.1530/ERC-18-0478. [Epub ahead of print]

PMID:
30576282
11.

Inhibition of miR‑194 suppresses the Wnt/β‑catenin signalling pathway in gastric cancer.

Peng Y, Zhang X, Lin H, Deng S, Huang Y, Qin Y, Feng X, Yan R, Zhao Y, Cheng Y, Wei Y, Wang J, Chen W, Fan X, Ashktorab H, Smoot D, Meltzer SJ, Li S, Zhang Z, Jin Z.

Oncol Rep. 2018 Dec;40(6):3323-3334. doi: 10.3892/or.2018.6773. Epub 2018 Oct 8.

12.

Multiple genetic mutations caused by NKX6.3 depletion contribute to gastric tumorigenesis.

Yoon JH, Kim O, Eun JW, Choi SS, Ashktorab H, Smoot DT, Nam SW, Park WS.

Sci Rep. 2018 Dec 4;8(1):17609. doi: 10.1038/s41598-018-35733-5.

13.

Correction to: Histone isoform H2A1H promotes attainment of distinct physiological states by altering chromatin dynamics.

Bhattacharya S, Reddy D, Jani V, Gadewal N, Shah S, Reddy R, Bose K, Sonavane U, Joshi R, Smoot D, Ashktorab H, Gupta S.

Epigenetics Chromatin. 2018 Nov 16;11(1):67. doi: 10.1186/s13072-018-0238-5.

14.

Synthetic Circular RNA Functions as a miR-21 Sponge to Suppress Gastric Carcinoma Cell Proliferation.

Liu X, Abraham JM, Cheng Y, Wang Z, Wang Z, Zhang G, Ashktorab H, Smoot DT, Cole RN, Boronina TN, DeVine LR, Talbot CC Jr, Liu Z, Meltzer SJ.

Mol Ther Nucleic Acids. 2018 Dec 7;13:312-321. doi: 10.1016/j.omtn.2018.09.010. Epub 2018 Sep 22.

15.

KMT2C Mutations in Diffuse-Type Gastric Adenocarcinoma Promote Epithelial-to-Mesenchymal Transition.

Cho SJ, Yoon C, Lee JH, Chang KK, Lin JX, Kim YH, Kook MC, Aksoy BA, Park DJ, Ashktorab H, Smoot DT, Schultz N, Yoon SS.

Clin Cancer Res. 2018 Dec 15;24(24):6556-6569. doi: 10.1158/1078-0432.CCR-17-1679. Epub 2018 Aug 14.

PMID:
30108106
16.

A Multilevel Approach to Stakeholder Engagement in the Formulation of a Clinical Data Research Network.

Boyer AP, Fair AM, Joosten YA, Dolor RJ, Williams NA, Sherden L, Stallings S, Smoot DT, Wilkins CH.

Med Care. 2018 Oct;56 Suppl 10 Suppl 1:S22-S26. doi: 10.1097/MLR.0000000000000778.

17.

Testin and filamin-C downregulation by acetylated Siah2 increases invasiveness of Helicobacter pylori-infected gastric cancer cells.

Kokate SB, Dixit P, Poirah I, Roy AD, Chakraborty D, Rout N, Singh SP, Ashktorab H, Smoot DT, Bhattacharyya A.

Int J Biochem Cell Biol. 2018 Oct;103:14-24. doi: 10.1016/j.biocel.2018.07.012. Epub 2018 Jul 29.

PMID:
30063986
18.

Clinicians' perspectives on and interest in participating in a clinical data research network across the Southeastern United States.

Unertl KM, Fair AM, Favours JS, Dolor RJ, Smoot D, Wilkins CH.

BMC Health Serv Res. 2018 Jul 20;18(1):568. doi: 10.1186/s12913-018-3399-9.

19.

Gastrokine 1 protein is a potential theragnostic target for gastric cancer.

Yoon JH, Ham IH, Kim O, Ashktorab H, Smoot DT, Nam SW, Lee JY, Hur H, Park WS.

Gastric Cancer. 2018 Nov;21(6):956-967. doi: 10.1007/s10120-018-0828-8. Epub 2018 Apr 27.

PMID:
29704153
20.

Screening and Identification of Peptides Specifically Targeted to Gastric Cancer Cells from a Phage Display Peptide Library

Sahin D, Taflan SO, Yartas G, Ashktorab H, Smoot DT.

Asian Pac J Cancer Prev. 2018 Apr 25;19(4):927-932.

21.

YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC.

Choi W, Kim J, Park J, Lee DH, Hwang D, Kim JH, Ashktorab H, Smoot D, Kim SY, Choi C, Koh GY, Lim DS.

Cancer Res. 2018 Jun 15;78(12):3306-3320. doi: 10.1158/0008-5472.CAN-17-3487. Epub 2018 Apr 18.

22.

Reduced lysosomal clearance of autophagosomes promotes survival and colonization of Helicobacter pylori.

Zhang L, Hu W, Cho CH, Chan FK, Yu J, Fitzgerald JR, Cheung CK, Xiao ZG, Shen J, Li LF, Li MX, Wu JC, Ling TK, Chan JY, Ko H, Tse G, Ng SC, Yu S, Wang MH, Gin T, Ashktorab H, Smoot DT, Wong SH, Chan MT, Wu WK.

J Pathol. 2018 Apr;244(4):432-444. doi: 10.1002/path.5033. Epub 2018 Feb 28.

PMID:
29327342
23.

Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.

Kang MH, Jeong GS, Smoot DT, Ashktorab H, Hwang CM, Kim BS, Kim HS, Park YY.

Oncotarget. 2017 Oct 19;8(58):98887-98897. doi: 10.18632/oncotarget.21946. eCollection 2017 Nov 17. Erratum in: Oncotarget. 2018 Dec 14;9(98):37268.

24.

Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.

Williams AD, Korolkova OY, Sakwe AM, Geiger TM, James SD, Muldoon RL, Herline AJ, Goodwin JS, Izban MG, Washington MK, Smoot DT, Ballard BR, Gazouli M, M'Koma AE.

PLoS One. 2017 Dec 6;12(12):e0189551. doi: 10.1371/journal.pone.0189551. eCollection 2017.

25.

Histone isoform H2A1H promotes attainment of distinct physiological states by altering chromatin dynamics.

Bhattacharya S, Reddy D, Jani V, Gadewal N, Shah S, Reddy R, Bose K, Sonavane U, Joshi R, Smoot D, Ashktorab H, Gupta S.

Epigenetics Chromatin. 2017 Oct 18;10(1):48. doi: 10.1186/s13072-017-0155-z. Erratum in: Epigenetics Chromatin. 2018 Nov 16;11(1):67.

26.

PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer.

Mimura K, Teh JL, Okayama H, Shiraishi K, Kua LF, Koh V, Smoot DT, Ashktorab H, Oike T, Suzuki Y, Fazreen Z, Asuncion BR, Shabbir A, Yong WP, So J, Soong R, Kono K.

Cancer Sci. 2018 Jan;109(1):43-53. doi: 10.1111/cas.13424. Epub 2017 Nov 18.

27.

Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.

Williams AD, Korolkova OY, Sakwe AM, Geiger TM, James SD, Muldoon RL, Herline AJ, Goodwin JS, Izban MG, Washington MK, Smoot DT, Ballard BR, Gazouli M, M'Koma AE.

PLoS One. 2017 Aug 17;12(8):e0179710. doi: 10.1371/journal.pone.0179710. eCollection 2017. Erratum in: PLoS One. 2017 Dec 6;12 (12 ):e0189551.

28.

Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma.

Qamra A, Xing M, Padmanabhan N, Kwok JJT, Zhang S, Xu C, Leong YS, Lee Lim AP, Tang Q, Ooi WF, Suling Lin J, Nandi T, Yao X, Ong X, Lee M, Tay ST, Keng ATL, Gondo Santoso E, Ng CCY, Ng A, Jusakul A, Smoot D, Ashktorab H, Rha SY, Yeoh KG, Peng Yong W, Chow PKH, Chan WH, Ong HS, Soo KC, Kim KM, Wong WK, Rozen SG, Teh BT, Kappei D, Lee J, Connolly J, Tan P.

Cancer Discov. 2017 Jun;7(6):630-651. doi: 10.1158/2159-8290.CD-16-1022. Epub 2017 Mar 20.

29.

Heterodimeric interaction between GKN2 and TFF1 entails synergistic antiproliferative and pro-apoptotic effects on gastric cancer cells.

Kim O, Yoon JH, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

Gastric Cancer. 2017 Sep;20(5):772-783. doi: 10.1007/s10120-017-0692-y. Epub 2017 Feb 1.

30.

Inhibition of histone/lysine acetyltransferase activity kills CoCl2-treated and hypoxia-exposed gastric cancer cells and reduces their invasiveness.

Rath S, Das L, Kokate SB, Ghosh N, Dixit P, Rout N, Singh SP, Chattopadhyay S, Ashktorab H, Smoot DT, Swamy MM, Kundu TK, Crowe SE, Bhattacharyya A.

Int J Biochem Cell Biol. 2017 Jan;82:28-40. doi: 10.1016/j.biocel.2016.11.014. Epub 2016 Nov 23.

31.

Race and colorectal cancer screening compliance among persons with a family history of cancer.

Laiyemo AO, Thompson N, Williams CD, Idowu KA, Bull-Henry K, Sherif ZA, Lee EL, Brim H, Ashktorab H, Platz EA, Smoot DT.

World J Gastrointest Endosc. 2015 Dec 10;7(18):1300-5. doi: 10.4253/wjge.v7.i18.1300.

32.

Gastrokine 1 inhibits gastrin-induced cell proliferation.

Kim O, Yoon JH, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

Gastric Cancer. 2016 Apr;19(2):381-391. doi: 10.1007/s10120-015-0483-2. Epub 2015 Mar 10.

33.

Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies.

Di Buduo CA, Wray LS, Tozzi L, Malara A, Chen Y, Ghezzi CE, Smoot D, Sfara C, Antonelli A, Spedden E, Bruni G, Staii C, De Marco L, Magnani M, Kaplan DL, Balduini A.

Blood. 2015 Apr 2;125(14):2254-64. doi: 10.1182/blood-2014-08-595561. Epub 2015 Jan 9.

34.

Gastrokine 1 inhibits the carcinogenic potentials of Helicobacter pylori CagA.

Yoon JH, Seo HS, Choi SS, Chae HS, Choi WS, Kim O, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

Carcinogenesis. 2014 Nov;35(11):2619-29. doi: 10.1093/carcin/bgu199. Epub 2014 Sep 19.

35.

Infrequent assessment of pain in elderly trauma patients.

Spilman SK, Baumhover LA, Lillegraven CL, Lederhaas G, Sahr SM, Schirmer LL, Smoot DL, Swegle JR.

J Trauma Nurs. 2014 Sep-Oct;21(5):229-35; quiz 236-7. doi: 10.1097/JTN.0000000000000070.

PMID:
25198078
36.

Factors associated with attendance to scheduled outpatient endoscopy.

Laiyemo AO, Williams CD, Burnside C, Moghadam S, Sanasi-Bhola KD, Kwagyan J, Brim H, Ashktorab H, Scott VF, Smoot DT.

Postgrad Med J. 2014 Oct;90(1068):571-5. doi: 10.1136/postgradmedj-2012-131650. Epub 2014 Sep 1.

37.

nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer.

Lee KS, Park JL, Lee K, Richardson LE, Johnson BH, Lee HS, Lee JS, Kim SB, Kwon OH, Song KS, Kim YS, Ashktorab H, Smoot DT, Jeon SH, Kim SY, Lee YS.

Oncotarget. 2014 Jun 15;5(11):3944-55.

38.

The effect of Helicobacter pylori CagA on the HER-2 copy number and expression in gastric cancer.

Shim JH, Yoon JH, Choi SS, Ashktorab H, Smoot DT, Song KY, Nam SW, Lee JY, Park CH, Park WS.

Gene. 2014 Aug 10;546(2):288-96. doi: 10.1016/j.gene.2014.05.064. Epub 2014 May 28.

39.

Gastric Helicobacter pylori infection associates with an increased risk of colorectal polyps in African Americans.

Brim H, Zahaf M, Laiyemo AO, Nouraie M, Pérez-Pérez GI, Smoot DT, Lee E, Razjouyan H, Ashktorab H.

BMC Cancer. 2014 Apr 28;14:296. doi: 10.1186/1471-2407-14-296.

40.

MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer.

Shin JY, Kim YI, Cho SJ, Lee MK, Kook MC, Lee JH, Lee SS, Ashktorab H, Smoot DT, Ryu KW, Kim YW, Choi IJ.

PLoS One. 2014 Jan 21;9(1):e85205. doi: 10.1371/journal.pone.0085205. eCollection 2014.

41.

Intravenous metoprolol versus diltiazem for rate control in noncardiac, nonthoracic postoperative atrial fibrillation.

Personett HA, Smoot DL, Stollings JL, Sawyer M, Oyen LJ.

Ann Pharmacother. 2014 Mar;48(3):314-9. doi: 10.1177/1060028013512473. Epub 2014 Jan 9.

PMID:
24408816
42.

GKN2 contributes to the homeostasis of gastric mucosa by inhibiting GKN1 activity.

Kim O, Yoon JH, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

J Cell Physiol. 2014 Jun;229(6):762-71. doi: 10.1002/jcp.24496.

PMID:
24151046
43.

Adenocarcinomas After Prophylactic Surgery For Familial Adenomatous Polyposis.

Smith JC, Schäffer MW, Ballard BR, Smoot DT, Herline AJ, Adunyah SE, M'Koma AE.

J Cancer Ther. 2013;4(1):260-270.

44.

GKN1-miR-185-DNMT1 axis suppresses gastric carcinogenesis through regulation of epigenetic alteration and cell cycle.

Yoon JH, Choi YJ, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

Clin Cancer Res. 2013 Sep 1;19(17):4599-610. doi: 10.1158/1078-0432.CCR-12-3675. Epub 2013 Jul 11.

45.

Gastrokine 1 regulates NF-κB signaling pathway and cytokine expression in gastric cancers.

Yoon JH, Cho ML, Choi YJ, Back JY, Park MK, Lee SW, Choi BJ, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

J Cell Biochem. 2013 Aug;114(8):1800-9. doi: 10.1002/jcb.24524.

46.

Short- and long-term risk of colorectal adenoma recurrence among whites and blacks.

Laiyemo AO, Doubeni C, Brim H, Ashktorab H, Schoen RE, Gupta S, Charabaty A, Lanza E, Smoot DT, Platz E, Cross AJ.

Gastrointest Endosc. 2013 Mar;77(3):447-54. doi: 10.1016/j.gie.2012.11.027. Epub 2013 Jan 18.

47.

The development and feasibility of a remote damage control resuscitation prehospital plasma transfusion protocol for warfarin reversal for patients with traumatic brain injury.

Zielinski MD, Smoot DL, Stubbs JR, Jenkins DH, Park MS, Zietlow SP.

Transfusion. 2013 Jan;53 Suppl 1:59S-64S. doi: 10.1111/trf.12037.

PMID:
23301974
48.

SILAC-based quantitative proteomic analysis of gastric cancer secretome.

Marimuthu A, Subbannayya Y, Sahasrabuddhe NA, Balakrishnan L, Syed N, Sekhar NR, Katte TV, Pinto SM, Srikanth SM, Kumar P, Pawar H, Kashyap MK, Maharudraiah J, Ashktorab H, Smoot DT, Ramaswamy G, Kumar RV, Cheng Y, Meltzer SJ, Roa JC, Chaerkady R, Prasad TS, Harsha HC, Chatterjee A, Pandey A.

Proteomics Clin Appl. 2013 Jun;7(5-6):355-66. doi: 10.1002/prca.201200069. Epub 2013 May 21.

49.

Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker: implications in molecular imaging.

Yang Y, Toy W, Choong LY, Hou P, Ashktorab H, Smoot DT, Yeoh KG, Lim YP.

J Proteome Res. 2012 Dec 7;11(12):5736-47. doi: 10.1021/pr300555y. Epub 2012 Nov 26.

50.

Helicobacter pylori protection against reflux esophagitis.

Ashktorab H, Entezari O, Nouraie M, Dowlati E, Frederick W, Woods A, Lee E, Brim H, Smoot DT, Ghadyari F, Kamangar F, Razjouyan H.

Dig Dis Sci. 2012 Nov;57(11):2924-8. doi: 10.1007/s10620-012-2349-3. Epub 2012 Sep 26.

Supplemental Content

Support Center